Weightbearing Restrictions on Postoperative Outcomes Following Arthroscopic Surgery for FAI

Last updated: April 1, 2024
Sponsor: Panam Clinic
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Weight-bearing As Tolerated

Partial Weight-bearing

Clinical Study ID

NCT05280899
Hip WB RCT
  • Ages 16-50
  • All Genders

Study Summary

The purpose of this single-blinded (assessor) randomized trial is to compare patient-reported, clinical and functional outcomes in patients randomized to weight-bearing as tolerated (WBAT) or partial weight-bearing (PWB) restrictions following arthroscopic surgery for femoroacetabular impingement (FAI) up to 12-months postoperative.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • 16 - 50 years of age at time of surgery
  • Diagnosis of FAI (cam, pincer, mixed) based on the 2016 Warwick Agreement. All 3criteria below must be met:
  1. Symptoms of motion- or position-related pain in the hip or groin
  2. Clinical signs consistent with FAI such as: decreased hip flexion and internalrotation, or positive impingement sign
  3. Radiographic evidence (on BOTH x-ray AND non-contrast MRI) of intra-articularpathology consistent with FAI as determined by the treating surgeon.
  • Failed conservative interventions of at least 3 months (i.e. physiotherapy)
  • Have symptom relief with intra-articular injection of local anaesthetic
  • Unilateral or bilateral surgical intervention (note: unilateral required to ensure theweight bearing guidelines are followed)
  • Are willing to be followed for 12 months post-operative. Eligibility for 'return to sport' cohort: Additional assessment measures related to return to sport will be collected on the patientwho meet the following criteria:
  • are or were previously actively involved in sport as indicated by a pre-operative HipSports Activity Scale score of four of greater
  • indicate a post-operative goal to return to sport following their procedure

Exclusion

Exclusion Criteria: Clinical:

  • Previous surgery on the affected hip, or other major lower extremity orthopaedicsurgery
  • Active joint or systemic infection, significant muscle paralysis, significant lowerextremity or medical comorbidity that could alter the effectiveness of the surgicalintervention (e.g. polymyalgia rheumatica)
  • Unable to speak or read English/French
  • Unable or unwilling to be followed for 1 year or complete functional testing
  • Presence of chronic pain syndromes
  • History of pediatric hip disease (i.e. Slipped Capital Femoral Epiphysis,Legg-Calve-Perthes Disease)
  • Ongoing litigation or compensation claims related to the hip (including Workers'Compensation) Radiographic:
  • Osteoarthritis greater than Tönnis Grade 1 on affected hip
  • Lateral central edge angle <19°
  • Dysplasia in patients with broken Shenton line (i.e. Severe acetabular deformitypresent)

Study Design

Total Participants: 88
Treatment Group(s): 2
Primary Treatment: Weight-bearing As Tolerated
Phase:
Study Start date:
September 01, 2022
Estimated Completion Date:
April 01, 2026

Study Description

The purpose of this single-blinded (assessor) randomized trial is to compare patient-reported, clinical and functional outcomes in patients randomized to weight-bearing as tolerated (WBAT) or partial weight-bearing (PWB) restrictions following arthroscopic surgery for femoroacetabular impingement (FAI) up to 12-months postoperative. The primary objective is to compare the effects of WBAT or PWB restrictions on PROMS (International Hip Outcome Tool (iHOT33)) and clinical measures following arthroscopic intervention for FAI up to one-year post-operative. The secondary objective will be to assess differences in return to sport (RTS) PROMS, functional performance, and lower extremity kinetics, kinematics, and muscle activity during in patients randomized to either WBAT or PWB at six- and 12-months post-operative. The goal will be to answer if there are differences between a WBAT versus PWB rehabilitation protocol on patient-reported quality of life as measured by the International Hip Outcome Tool (iHOT33) at 12-m post-operative for patients undergoing primary hip arthroscopy for the treatment of FAI.

Connect with a study center

  • Pan Am Clinic

    Winnipeg, Manitoba R3M 3E4
    Canada

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.